Raffles Medical Group Ltd
RAFLF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -2.1% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.9% | 45.9% | 45.2% | 45.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 16.5% | 16.5% | 14.2% | 14.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.5% | 8.5% | 8.2% | 8.2% |
| EPS Diluted | 0.009 | 0.009 | 0.009 | 0.009 |
| % Growth | 0% | 1.2% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |